Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7060 results

Novartis returns rights to Enanta’s NS5A Inhibitor EDP-239 for hep C

01-10-2014

USA-based discovery and development company Enanta Pharmaceuticals says it has entered into an agreement…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

Islet Sciences announces merger with Brighthaven Ventures

Islet Sciences announces merger with Brighthaven Ventures

01-10-2014

Metabolic biopharma specialist Islet Sciences has announced a merger with Brighthaven Ventures, a privately-held…

Islet SciencesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalremogliflozinUSA

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

01-10-2014

French drugmaker Erytech and Italy's Recordati have reported positive Phase III results from its study…

Erytech PharmaGraspaOncologyPharmaceuticalRecordatiResearch

Legal change to reduce patent infringements could attract drug research back to the UK

Legal change to reduce patent infringements could attract drug research back to the UK

01-10-2014

A legal amendment which takes effect today could help to attract drug research back to the UK, according…

LegalPatentsPharmaceuticalUKUnited Kingdom

Health Canada issues import ban from three Indian drug plants

Health Canada issues import ban from three Indian drug plants

01-10-2014

Regulator Health Canada has taken action to stop the imports from three Indian manufacturing sites.

Apotex Research Private LimitedCanadaIndiaIpca LaboratoriesPharmaceuticalRegulation

EC guideline on facilitating applications for pediatric investigation plans

01-10-2014

The European Commission has published a revised guideline on applications for pediatric investigation…

EuropePharmaceuticalResearch

FDA grants to stimulate drug and device development for rare diseases

01-10-2014

The US Food and Drug Administration yesterday announced it has awarded 15 grants totaling more than $19…

FinancialPharmaceuticalRare diseasesResearchUSA

Long-acting insulin is safer, more effective for patients with type 1 diabetes

01-10-2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type…

DiabetesInsulin DetemirInsulin Glargine [rDNA origin] InjectionPharmaceuticalResearch

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

01-10-2014

The annual congress of the European Society for Medical Oncology (ESMO) came to a close in Madrid, Spain,…

AstraZenecaAZD9291IressaOncologyPharmaceuticalResearchUK

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

01-10-2014

Japanese drug major Astellas Pharma and Medivation has received extended approval for Xtandi (enzalutamide)…

Astellas PharmaDiplomatMedivationOncologyPharmaceuticalRegulationUSAXtandi

Ritter appoints Michael Step as chief executive

Ritter appoints Michael Step as chief executive

01-10-2014

Privately-held gastrointestinal company Ritter Pharmaceuticals has appointed Michael Step as chief executive.

BoardroomGastro-intestinalsPharmaceuticalRitterUSA

US pharma and device firms paid doctors/hospitals ~$3.5 billion, CMS data show

01-10-2014

As part of its ongoing effort to increase transparency and accountability in health care, the Centers…

FinancialMedicare & Medicaid ServicesPharmaceuticalResearchUSA

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

30-09-2014

An orphan drug could offer real hope to patients with rare thyroid cancer, Japanese drugmaker Eisai revealed…

EisaiInterviewsJapanlenvatinibOncologyPharmaceuticalResearch

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

Pfizer and Kyowa Hakko collaborate on immuno-oncology combination study

30-09-2014

US pharma major Pfizer and Japanese drugmaker Kyowa Hakko Kirin have entered into an agreement to explore…

ImmunologicalsKyowa Hakko KirinmogamulizumabOncologyPF-05082566PfizerPharmaceuticalResearch

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

30-09-2014

Belgian drugmaker UCB has launched an awareness-raising campaign around brain-related illnesses such…

EuropeNeurologicalPharmaceuticalSocial IssuesUCB

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

1 to 25 of 7060 results

Back to top